Kus J, Tse K S, Enarson D, Grzybowski S, Chan-Yeung M
Allergy. 1984 Oct;39(7):509-14. doi: 10.1111/j.1398-9995.1984.tb00871.x.
The lymphocyte subpopulations were classified using monoclonal antibodies specific for B lymphocytes (B1 antibodies), T lymphocytes (T11 and OKT3 antibodies), helper/inducer T cells (T4 antibodies) and suppressor/cytotoxic T cells (T8 antibodies). Three groups of subjects were studied: 20 normal controls, 29 patients with allergic rhinitis and a subgroup of nine patients who had received immunotherapy. The proportion of B lymphocytes, total T cells and T4 positive (helper/inducer) cells were not significantly different between the groups, but allergic patients were found to have a decreased proportion of suppressor T8 positive (suppressor/cytotoxic) cells and hence a high helper/suppressor cell ratio. These abnormal parameters were found to be normal in the group of allergic patients who had received immunotherapy. These results imply that a suppressor cell deficiency may be an underlying mechanism of allergic disease, and that immunotherapy could correct the suppressor cell deficiency.
使用针对B淋巴细胞(B1抗体)、T淋巴细胞(T11和OKT3抗体)、辅助/诱导性T细胞(T4抗体)和抑制/细胞毒性T细胞(T8抗体)的单克隆抗体对淋巴细胞亚群进行分类。研究了三组受试者:20名正常对照者、29名变应性鼻炎患者以及9名接受过免疫治疗的患者亚组。各组之间B淋巴细胞、总T细胞和T4阳性(辅助/诱导性)细胞的比例无显著差异,但发现变应性患者中抑制性T8阳性(抑制/细胞毒性)细胞的比例降低,因此辅助/抑制细胞比值较高。在接受过免疫治疗的变应性患者组中,这些异常参数恢复正常。这些结果表明,抑制细胞缺陷可能是变应性疾病的潜在机制,并且免疫治疗可以纠正抑制细胞缺陷。